Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -9.46 is 88% above its 5-year average of -78.92, near the high end of its 5-year range (-162.20–-8.44).
33.47% above its 12-month average of -14.22.
Reported quarterly EPS; no daily interpolation. Q4 FY2026 (2026-06-30): -1.34.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 33 comparable quarters.
EARNINGS PER SHARE (EPS)
-9.46
EARNINGS PER SHARE (EPS) AVG TTM
-14.22
EARNINGS PER SHARE (EPS) AVG 3Y
-49.51
EARNINGS PER SHARE (EPS) AVG 5Y
-78.92
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+33.47%
CURRENT VS 3Y AVG
+80.89%
CURRENT VS 5Y AVG
+88.01%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Intelligent Bio Solutions Inc.
Market Cap
$5.27M
Earnings Per Share (EPS)
-9.46
TTM Avg
-14.22
3Y Avg
-49.51
5Y Avg
-78.92
Market Cap
$5.24M
Earnings Per Share (EPS)
-1.10
TTM Avg
-2.02
3Y Avg
-3.33
5Y Avg
-6.96
Market Cap
$5.29M
Earnings Per Share (EPS)
-2.30
TTM Avg
-6.97
3Y Avg
-88.06
5Y Avg
-105.56
Market Cap
$5.21M
Earnings Per Share (EPS)
-61.25
TTM Avg
-79.52
3Y Avg
-97.16
5Y Avg
-86.80
Market Cap
$5.20M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.61
3Y Avg
-0.43
5Y Avg
-0.43
Market Cap
$5.17M
Earnings Per Share (EPS)
-23.70
TTM Avg
-20.75
3Y Avg
-13.28
5Y Avg
-9.32
Market Cap
$5.08M
Earnings Per Share (EPS)
-4.53
TTM Avg
-13.96
3Y Avg
-30.40
5Y Avg
-166.98
Market Cap
$5.23M
Earnings Per Share (EPS)
N/A
TTM Avg
0.00
3Y Avg
-0.12
5Y Avg
-0.11
Market Cap
$5.72M
Earnings Per Share (EPS)
-3.55
TTM Avg
-11.46
3Y Avg
-17.07
5Y Avg
-17.09
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intelligent Bio Solutions Inc. (INBS) | $5.27M | -9.46 | -14.22 | -49.51 | -78.92 |
| Pulmatrix, Inc. (PULM)vs › | $5.24M | -1.10 | -2.02 | -3.33 | -6.96 |
| Alzamend Neuro Inc (ALZN)vs › | $5.29M | -2.30 | -6.97 | -88.06 | -105.56 |
| Lunai Bioworks Inc. (LNAI)vs › | $5.21M | -61.25 | -79.52 | -97.16 | -86.80 |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.20M | N/A | -1.61 | -0.43 | -0.43 |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.17M | -23.70 | -20.75 | -13.28 | -9.32 |
| Imunon, Inc. (IMNN)vs › | $5.08M | -4.53 | -13.96 | -30.40 | -166.98 |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.23M | N/A | 0.00 | -0.12 | -0.11 |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.72M | -3.55 | -11.46 | -17.07 | -17.09 |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.63M | N/A | -0.92 | -0.62 | -0.53 |
Trailing EPS (TTM)
$-9.46
Forward EPS (Est.)
$-5.18
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-06-30 | -8.44 |
| 2025-06-30 | -20.00 |
| 2024-06-30 | -63.80 |
| 2023-06-30 | -105.80 |
| 2022-06-30 | -113.30 |
| 2021-06-30 | -162.20 |
| 2020-06-30 | -89.20 |
| 2019-06-30 | -210.10 |
| 2018-06-30 | -146.00 |
| 2017-06-30 | -9.90 |
